Accessibility: Skip TopNav
Chris Liu, Ph.D.
Chris Liu, Ph.D., Senior Research Analyst specializing in oncology at RTW Investments, LP, was appointed to Artios' Board of Directors
Format
JPEG
Quelle:
Artios Pharma, Inc.
Downloads
Originalgröße
Groß
Mittel
Klein